850101P

13:0 Lyso PI

1-tridecanoyl-2-hydroxy-sn-glycero-3-phospho-(1′-myo-inositol) (ammonium salt), powder

• 동의어(들): PI(13:0/0:0); 110716
• 실험식(Hill 표기법): C₂₂H₄₆NO₁₂P
• CAS Number: 1246430-02-3
• Molecular Weight: 547.57
• UNSPSC 코드: 51191904
• NACRES: NA.25

속성

• 분석: >99% (LPI; may contain up to 10% of the 2-LPI isomer, TLC)
• 양식: powder
• 포장: pkg of 1 × 100 μg (with stopper and crimp cap (850101P-100ug)); pkg of 1 × 500 μg (with stopper and crimp cap (850101P-500ug))
• 제조업체/상표: Avanti Research^™ - A Croda Brand 850101P
• 지질 유형: phospholipids; cardiolipins
• 배송 상태: dry ice
• 저장 온도: −20°C
• SMILES string: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O)=O)(O)COC(CCCCCCCCCCCC)=O.[NH4+]

설명

일반 설명

Lysophosphatidylinositol (LPI), produced by phospholipase A2 is a bioactive lipid.

애플리케이션

13:0 Lyso PI (1-tridecanoyl-2-hydroxy-sn-glycero-3-phospho-(1′-myo-inositol) may be used as a nonendogenous phospholipid (PL) standard for the quantitative analysis of PLs. It may also be used as a standard for tandem mass spectrometry analysis of lipid species in human plasma.

생화학적/생리학적 작용

Increased circulating levels of L-alpha-lysophosphatidylinositol (LPI) are associated with cancer and LPI is a potent ligand for the G-protein-coupled receptor GPR55.

Lysophosphatidylinositol (LPI) is expected to play a vital role in various diseases. Ca²⁺ channels at the plasma membrane and mitochondrial membrane are controlled by LPI. It can also stimulate various signaling pathways to control several cellular processes. LPI can block the migration of cells.

포장

2 mL Amber Serum Vial with Stopper and Crimp Cap (850101P-100ug)

2 mL Amber Serum Vial with Stopper and Crimp Cap (850101P-500ug)

법적 정보

Avanti Research is a trademark of Avanti Polar Lipids, LLC

안전성 정보

• Storage Class Code: 11 - Combustible Solids